Thiogenesis Therapeutics, Corp. TTIPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 691.53% | -45.09% | -53.12% | 86.01% | -35.55% |
| Total Receivables | 100.00% | -66.25% | 14.52% | 37.36% | -10.55% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -20.84% | -19.75% | 126.14% | 10.99% | -16.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 607.32% | -44.28% | -49.14% | 82.94% | -34.73% |
|
|
|||||
| Total Current Assets | 607.32% | -44.28% | -49.14% | 82.94% | -34.73% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 607.32% | -44.28% | -49.14% | 82.94% | -34.73% |
|
|
|||||
| Total Accounts Payable | -45.98% | -1.24% | -13.88% | -3.42% | 60.14% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -46.36% | -0.54% | -14.38% | -2.85% | 57.36% |
|
|
|||||
| Total Current Liabilities | -46.36% | -0.54% | -14.38% | -2.85% | 57.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -46.36% | -0.54% | -14.38% | -2.85% | 57.36% |
|
|
|||||
| Common Stock & APIC | 38.57% | -1.77% | 1.63% | 20.25% | 5.39% |
| Retained Earnings | -4.76% | -2.35% | -10.39% | -11.18% | -18.14% |
| Treasury Stock & Other | 9.25% | 2.84% | 8.20% | 18.28% | 19.48% |
| Total Common Equity | 3,017.13% | -138.74% | -72.90% | 361.46% | -77.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3,017.13% | -138.74% | -72.90% | 361.46% | -77.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3,017.13% | -138.74% | -72.90% | 361.46% | -77.50% |
|
|
|||||